P865: biomarker analysis to support dose optimization of iberdomide as monotherapy and in combination with standard of care treatments for multiple myeloma from a phase 1/2 trial

M. Amatangelo,Y. Cheng, W. Pierceall,N. W. van de Donk,S. Lonial,M. Wang, J. Emerson,K. Hong, P. Maciag, T. Peluso, A. Gandhi,A. Thakurta

HemaSphere(2022)

引用 0|浏览0
暂无评分
关键词
multiple myeloma,iberdomide,monotherapy,support dose optimization
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要